160 related articles for article (PubMed ID: 12790776)
21. Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2.
Lin BR; Chang CC; Chen LR; Wu MH; Wang MY; Kuo IH; Chu CY; Chang KJ; Lee PH; Chen WJ; Kuo ML; Lin MT
Mol Cancer Res; 2007 Nov; 5(11):1111-23. PubMed ID: 18025257
[TBL] [Abstract][Full Text] [Related]
22. The matricellular protein CYR61 promotes breast cancer lung metastasis by facilitating tumor cell extravasation and suppressing anoikis.
Huang YT; Lan Q; Lorusso G; Duffey N; Rüegg C
Oncotarget; 2017 Feb; 8(6):9200-9215. PubMed ID: 27911269
[TBL] [Abstract][Full Text] [Related]
23. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway.
Tong X; O'Kelly J; Xie D; Mori A; Lemp N; McKenna R; Miller CW; Koeffler HP
Oncogene; 2004 Jun; 23(28):4847-55. PubMed ID: 15077166
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1.
Lin MT; Chang CC; Lin BR; Yang HY; Chu CY; Wu MH; Kuo ML
J Biol Chem; 2007 Nov; 282(47):34594-604. PubMed ID: 17905740
[TBL] [Abstract][Full Text] [Related]
25. Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes.
Liu H; Yang R; Tinner B; Choudhry A; Schutze N; Chaqour B
Endocrinology; 2008 Apr; 149(4):1666-77. PubMed ID: 18187544
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
Li J; Gao X; Ji K; Sanders AJ; Zhang Z; Jiang WG; Ji J; Ye L
Oncol Rep; 2016 Nov; 36(5):2517-2525. PubMed ID: 27633176
[TBL] [Abstract][Full Text] [Related]
27. Induction and function of CYR61 (CCN1) in prostatic stromal and epithelial cells: CYR61 is required for prostatic cell proliferation.
Sakamoto S; Yokoyama M; Aoki M; Suzuki K; Kakehi Y; Saito Y
Prostate; 2004 Dec; 61(4):305-17. PubMed ID: 15389821
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
Sampath D; Zhu Y; Winneker RC; Zhang Z
J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
[TBL] [Abstract][Full Text] [Related]
29. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.
Babic AM; Kireeva ML; Kolesnikova TV; Lau LF
Proc Natl Acad Sci U S A; 1998 May; 95(11):6355-60. PubMed ID: 9600969
[TBL] [Abstract][Full Text] [Related]
30. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium.
Gashaw I; Stiller S; Böing C; Kimmig R; Winterhager E
Endocrinology; 2008 May; 149(5):2261-9. PubMed ID: 18202125
[TBL] [Abstract][Full Text] [Related]
31. Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61.
Harris LG; Pannell LK; Singh S; Samant RS; Shevde LA
Oncogene; 2012 Jul; 31(28):3370-80. PubMed ID: 22056874
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer.
Holloway SE; Beck AW; Girard L; Jaber MR; Barnett CC; Brekken RA; Fleming JB
J Am Coll Surg; 2005 Mar; 200(3):371-7. PubMed ID: 15737847
[TBL] [Abstract][Full Text] [Related]
33. Functional domains of CCN1 (Cyr61) regulate breast cancer progression.
O'Kelly J; Chung A; Lemp N; Chumakova K; Yin D; Wang HJ; Said J; Gui D; Miller CW; Karlan BY; Koeffler HP
Int J Oncol; 2008 Jul; 33(1):59-67. PubMed ID: 18575751
[TBL] [Abstract][Full Text] [Related]
34. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.
Kireeva ML; MO FE; Yang GP; Lau LF
Mol Cell Biol; 1996 Apr; 16(4):1326-34. PubMed ID: 8657105
[TBL] [Abstract][Full Text] [Related]
35. Functional properties and intracellular signaling of CCN1/Cyr61.
Chen Y; Du XY
J Cell Biochem; 2007 Apr; 100(6):1337-45. PubMed ID: 17171641
[TBL] [Abstract][Full Text] [Related]
36. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.
Xie D; Yin D; Wang HJ; Liu GT; Elashoff R; Black K; Koeffler HP
Clin Cancer Res; 2004 Mar; 10(6):2072-81. PubMed ID: 15041728
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acid.
Sakamoto S; Yokoyama M; Zhang X; Prakash K; Nagao K; Hatanaka T; Getzenberg RH; Kakehi Y
Endocrinology; 2004 Jun; 145(6):2929-40. PubMed ID: 14988385
[TBL] [Abstract][Full Text] [Related]
38. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
[TBL] [Abstract][Full Text] [Related]
39. CCN proteins and cancer: two to tango.
Bleau AM; Planque N; Perbal B
Front Biosci; 2005 May; 10():998-1009. PubMed ID: 15769600
[TBL] [Abstract][Full Text] [Related]
40. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
